Enovix Corp
For the period ended Sep 28, 2025. Filed Nov 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 28, 2025 · Filed Nov 5, 2025
ENVX$2.64-5.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows for the
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Fiscal Years-to-Date Ended | ||
|---|---|---|
| (In thousands) | September 28, 2025 | September 29, 2024 |
| Cash flows used in operating activities: | ||
| Net loss | $(121,566) | $(185,082) |
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Depreciation, accretion and amortization | 26,675 | 37,417 |
| Stock-based compensation | 37,973 | 48,630 |
| Changes in fair value of common stock warrants | (11,778) | (17,359) |
| Gain on bargain purchase of assets | (4,761) | — |
| Impairment and loss on disposal of long-lived assets | — | 38,249 |
| Interest expense (non-cash) | 9,222 | — |
| Others | 1,312 | 174 |
| Changes in operating assets and liabilities: | ||
| Accounts and notes receivables | (2,359) | 494 |
| Inventory | (7,247) | (827) |
| Prepaid expenses and other assets | 445 | (3,913) |
| Accounts payable | 6,539 | (10,018) |
| Accrued expenses and compensation | (2,781) | 3,175 |
| Deferred revenue | 702 | (502) |
| Deferred tax liability | (1,135) | (3,303) |
| Other liabilities | 467 | 190 |
| Net cash used in operating activities | (68,292) | (92,675) |
| Cash flows from investing activities: | ||
| Purchase of property and equipment | (17,216) | (59,830) |
| Payment for business acquisition | (10,000) | — |
| Purchases of investments | (370,133) | (31,812) |
| Maturities of investments | 58,145 | 106,621 |
| Net cash provided by (used in) investing activities | (339,204) | 14,979 |
| Cash flows from financing activities: | ||
| Proceeds from issuance of convertible senior notes and loan borrowing | 360,000 | 4,572 |
| Payments of debt issuance costs | (9,900) | — |
| Repayment of debt | (794) | (180) |
| Purchase of Capped Calls | (45,288) | — |
| Proceeds from exercise of common stock warrants | 232,106 | — |
| Payments of issuance costs related to common stock and warrant dividends | (5,995) | — |
| Repurchase of common stock | (58,385) | — |
| Proceeds from the exercise of stock options and issuance of common stock under ATM, net of issuance costs | 3,133 | 44,285 |
| Payroll tax payments for shares withheld upon vesting of RSUs | (4,855) | (5,601) |
| Proceeds from issuance of common stock under employee stock purchase plan | 711 | 1,145 |
| Repurchase of unvested restricted common stock | — | (4) |
| Net cash provided by financing activities | 470,733 | 44,217 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (409) | 1,303 |
| Change in cash, cash equivalents, and restricted cash | 62,828 | (32,176) |
| Cash and cash equivalents and restricted cash, beginning of period | 274,691 | 235,123 |
| Cash and cash equivalents and restricted cash, end of period | $337,519 | $202,947 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
| Fiscal Years-to-Date Ended | ||
|---|---|---|
| (In thousands) | September 28, 2025 | September 29, 2024 |
| Supplemental cash flow disclosure: | ||
| Cash paid for interest | $2,971 | $2,951 |
| Cash paid for income taxes | 1,072 | 164 |
| Supplemental non-cash investing and financing activities: | ||
| Purchase of property and equipment included in liabilities | $8,146 | $14,478 |
| Cashless warrant exercise | — | 2,276 |
| Accrued debt issuance costs | 1,500 | — |
| Accrued issuance costs related to the Warrants | 1,082 | — |
The following presents our cash, cash equivalents and restricted cash by category in the Condensed Consolidated Balance Sheets:
| Fiscal Years-to-Date Ended | ||
|---|---|---|
| (In thousands) | September 28, 2025 | September 29, 2024 |
| Cash and cash equivalents | $335,502 | $200,912 |
| Restricted cash included in prepaid expenses, other current assets and other assets, non-current | 2,017 | 2,035 |
| Total cash, cash equivalents, and restricted cash | $337,519 | $202,947 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.